Metabolism of dextromethorphan in human liver microsomes: A rapid HPCL assay to monitor cytochrome P450 2D6 activity

被引:0
|
作者
Vielnascher, E
Spatzenegger, M
Mayrhofer, A
Klinger, P
Jager, W
机构
[1] UNIV VIENNA, INST PHARMACEUT CHEM, A-1090 VIENNA, AUSTRIA
[2] NATL INST QUAL CONTROL DRUGS, VIENNA, AUSTRIA
[3] UNIV INNSBRUCK, DEPT SURG 2, A-6020 INNSBRUCK, AUSTRIA
来源
PHARMAZIE | 1996年 / 51卷 / 08期
关键词
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A new HPLC assay was developed to study dextromethorphan O-demethylation to dextrophan in vitro using human liver microsomes to investigate the activity of the polymorphic monooxygenase cytochrome P450 2D6 (CYP 2D6). The separation of dextromethorphan and its main metabolite dextrorphan was performed on a polymeric C18 reversed-phase column with UV-detection using levallorphan as an internal standard. Liver samples from ten subjects were screened for dextrorphan formation whereby three groups with different abilities to metabolize dextromethorphan could be found. Seven microsomal preparations from extensive metabolizers showed an average dextrorphan formation rate of 298 +/- 68 pmol/mg protein . min, one sample was classified to belong to an intermediate dextromethorphan metabolizer (79 pmol/mg protein min), whereas two samples of poor metabolizers exhibited significantly lower rates of dextromethorphan metabolism with values of 11 and 27 pmol/mg protein . min, respectively. This assay permits not only a fast in vitro screening for cytochrome P450 2D6 monooxygenase activity but is also an excellant tool to determine potential drug-drug interactions with this important metabolizing enzyme.
引用
收藏
页码:586 / 588
页数:3
相关论文
共 50 条
  • [21] Rapid detection of common cytochrome P450 2D6 alleles in Caucasians
    Roberts, RL
    Kennedy, MA
    CLINICA CHIMICA ACTA, 2006, 366 (1-2) : 348 - 351
  • [22] Cytochrome P450 2D6 as a Model Antigen
    Christen, Urs
    Holdener, Martin
    Hintermann, Edith
    DIGESTIVE DISEASES, 2010, 28 (01) : 80 - 85
  • [23] Substrate specific metabolism by polymorphic cytochrome P450 2D6 alleles
    Bogni, A
    Monshouwer, M
    Moscone, A
    Hidestrand, M
    Ingelman-Sundberg, M
    Hartung, T
    Coecke, S
    TOXICOLOGY IN VITRO, 2005, 19 (05) : 621 - 629
  • [24] Determinants of Cytochrome P450 2D6 mRNA Levels in Healthy Human Liver Tissue
    Ning, Miaoran
    Duarte, Julio D.
    Stevison, Faith
    Isoherranen, Nina
    Rubin, Leah H.
    Jeong, Hyunyoung
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2019, 12 (04): : 416 - 423
  • [25] Ziprasidone and the activity of cytochrome P450 2D6 in healthy extensive metabolizers
    Wilner, KD
    Demattos, SB
    Anziano, RJ
    Apseloff, G
    Gerber, N
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 49 : 43S - 47S
  • [26] Arylacetamide κ agonists with reduced cytochrome P450 2D6 activity.
    Ajello, CW
    Le Bourdonnec, B
    Cassel, JA
    Stabley, G
    Belanger, S
    DeHaven, RN
    Dolle, RE
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U915 - U915
  • [27] Validation of a rapid microtiter plate assay to conduct cytochrome P450 2D6 enzyme inhibition studies
    Palamanda, JR
    Favreau, L
    Lin, CC
    Nomeir, AA
    DRUG DISCOVERY TODAY, 1998, 3 (10) : 466 - 470
  • [28] Cytochrome P450 2D6 activity predicts adherence to tamoxifen therapy
    Rae, J. M.
    Sikora, M. J.
    Henry, N. L.
    Li, L.
    Kim, S.
    Oesterreich, S.
    Skaar, T.
    Nguyen, A. T.
    Desta, Z.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S21 - S21
  • [29] Kinetics of bromodichloromethane metabolism by cytochrome P450 isoenzymes in human liver microsomes
    Zhao, GY
    Allis, JW
    CHEMICO-BIOLOGICAL INTERACTIONS, 2002, 140 (02) : 155 - 168
  • [30] Metabolism of β-arteether to dihydroqinghaosu by human liver microsomes and recombinant cytochrome P450
    Grace, JM
    Aguilar, AJ
    Trotman, KM
    Brewer, TG
    DRUG METABOLISM AND DISPOSITION, 1998, 26 (04) : 313 - 317